NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

NCT02117375

CompletedNA

Sponsor: Rennes University Hospital

Conditions: Multiple Sclerosis

Interventions: spinal cord MRI follow-up, clinical follow-up, brain MRI follow-up

Countries: France

The purpose of this study is to evaluate the prognostic value of early focal lesions and early diffuse lesions on ambulatory disability progression within 5 years after clinical onset.

Eligibility overview

Sex: ALL

Age: 18 Years to 40 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Patients with multiple sclerosis:

Inclusion Criteria:

* Relapsing Remitting Multiple Sclerosis patients (Mac Donald 2010 criteria)
* First clinical event \< 1 year
* Brain MRI \> 9 lesions or/and spinal cord attack with focal lesion on spinal cord MRI
* Score Expended Disability Status Scale \< 3
* Age between 18 and 40 years

Exclusion Criteria:

* Multiple Sclerosis progressive
* Patients treated with immunosuppressive therapy
* Pregnancy

Healthy volunteers:

Inclusion Criteria:

-Age between 18 and 40 years

Exclusion Criteria:

-Pregnancy
Locations (1)
  • Rennes, France